NA49 augmented the cell death in EGFR-WT cells when combined with Gef, and depletion of HSP27 diminished these effects, suggesting HSP27 inhibition as a potential chemo-sensitization target for Gef treatment in EGFR-WT cancer cells. This evidence concerns the gene EGFR and cancer.